INTI
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 25 closing price
Capitalization
8.54M
Intraday BUY SELL Signals
IVEVF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
813.98M
Intraday BUY SELL Signals
Interact to see
Advertisement

INTI vs IVEVF

Header iconINTI vs IVEVF Comparison
Open Charts INTI vs IVEVFBanner chart's image
Inhibitor Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$6K
Capitalization8.54M
INVENTIVA SA
PriceLoading...
Change-$0.00 (-0.00%)
Volume$600
Capitalization813.98M
INTI vs IVEVF Comparison Chart in %
INTI
Daily Signal:
Gain/Loss:
IVEVF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INTI vs. IVEVF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INTI is a Buy and IVEVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (INTI: $0.05 vs. IVEVF: $4.44)
Brand notoriety: INTI and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INTI: 26% vs. IVEVF: 81%
Market capitalization -- INTI: $8.54M vs. IVEVF: $813.98M
INTI [@Biotechnology] is valued at $8.54M. IVEVF’s [@Biotechnology] market capitalization is $813.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INTI’s FA Score shows that 0 FA rating(s) are green whileIVEVF’s FA Score has 1 green FA rating(s).

  • INTI’s FA Score: 0 green, 5 red.
  • IVEVF’s FA Score: 1 green, 4 red.
According to our system of comparison, IVEVF is a better buy in the long-term than INTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INTI’s TA Score shows that 5 TA indicator(s) are bullish while IVEVF’s TA Score has 1 bullish TA indicator(s).

  • INTI’s TA Score: 5 bullish, 3 bearish.
  • IVEVF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, INTI is a better buy in the short-term than IVEVF.

Price Growth

INTI (@Biotechnology) experienced а 0.00% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.75%. For the same industry, the average monthly price growth was +5.41%, and the average quarterly price growth was +55.63%.

Industries' Descriptions

@Biotechnology (+0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVEVF($814M) has a higher market cap than INTI($8.54M). IVEVF YTD gains are higher at: 21.978 vs. INTI (-17.637).
INTIIVEVFINTI / IVEVF
Capitalization8.54M814M1%
EBITDA-3.67MN/A-
Gain YTD-17.63721.978-80%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash3.74MN/A-
Total Debt78.1KN/A-
FUNDAMENTALS RATINGS
INTI: Fundamental Ratings
INTI
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INTIIVEVF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 7 days ago
17%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
15%
Advances
ODDS (%)
Bullish Trend 15 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INTI
Daily Signal:
Gain/Loss:
IVEVF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGEN7.050.61
+9.47%
Tecogen Inc
CBRE162.282.95
+1.85%
Cbre Group
PECO34.87-0.10
-0.29%
Phillips Edison & Company
UFCS36.16-0.18
-0.50%
United Fire Group
TRAW2.11-0.05
-2.31%
Traws Pharma Inc

INTI and

Correlation & Price change

A.I.dvisor tells us that INTI and QRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTI and QRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
QRON - INTI
24%
Poorly correlated
N/A
DWTX - INTI
23%
Poorly correlated
-0.16%
IVEVF - INTI
17%
Poorly correlated
N/A
IVBXF - INTI
11%
Poorly correlated
-3.01%
ISCO - INTI
7%
Poorly correlated
N/A
More

IVEVF and

Correlation & Price change

A.I.dvisor tells us that IVEVF and DTIL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVEVF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
DTIL - IVEVF
32%
Poorly correlated
+5.64%
MIST - IVEVF
28%
Poorly correlated
-1.13%
IDRSF - IVEVF
21%
Poorly correlated
+10.89%
INTI - IVEVF
17%
Poorly correlated
N/A
INNMF - IVEVF
15%
Poorly correlated
-9.71%
More